India has launched BIRSA 101, the nation’s first indigenous CRISPR-based gene therapy for Sickle Cell Disease, marking a ...
Science and Technology Minister Jitendra Singh on Wednesday launched India’s first indigenous CRISPR-based gene therapy for ...
USA News Group News Commentary ? The autologous cell therapy market surpassed $10.1 billion in 2025 as biotechnology companies race to commercialize therapies that read, replace, and rewrite cellular ...
Setting a new milestone in Atmanirbhar Bharat, the government on Wednesday launched an indigenous CRISPR-based gene therapy ...
ToolGen (KOSDAQ: 199800; CEO Jong-sang Ryu), a leader in genome editing technology, announced that the United States Patent ...
Science and Technology Minister, Dr. Jitendra Singh today launched country’s first indigenous CRISPR based gene therapy for ...
ARK Invest bought $7.9M in Roblox shares and sold $5.2M in Pinterest stock on Nov 18, 2025. Full details on Cathie Wood's latest ETF trades and positions.
Fantasy Impact: The backfield in New York should revert to a timeshare headed by veteran Tyrone Tracy in Skattebo's absence.
South Africa battles its worst drought in a century — but DSTI’s new STI Roadmap is fighting back with CRISPR crops, smart ...
Future Market Insights provides reliable, data-driven insights that empower stakeholders to make informed decisions in the ...
Scientists are genetically engineering microbes to withstand industrial conditions for biofuel production. Researchers found that partially suppressing genes in cyanobacteria improved their growth ...
The breakthrough marks the country’s entry into advanced gene-editing therapeutics, an area so far dominated by a handful of global companies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback